2003 Feb;24(2):307-11
Implications of VNS in obesity, MASLD, MASH, and cancer Given the complex interplay between metabolic dysregulation and obesity-related diseases, including metabolic-associated steatotic liver disease (MASLD), metabolic-associated steatohepatitis (MASH), and cancer, VNS offers a promising avenue for therapeutic intervention: VNS directly addresses the dysregulated energy balance by reducing appetite, enhancing satiety, and promoting metabolic efficiency
Some studies show increases in beneficial bacteria like Akkermansia muciniphila (the superstar of gut health), while others reveal concerning decreases in overall microbial diversity
Ozempic (semaglutide): Similar to Wegovy, Ozempic is a GLP-1 receptor agonist used to treat type 2 diabetes
Some studies show BPC-157 modulates nitric oxide pathways and regulatory proteins involved in inflammation and tissue repair
Most tendon, ligament, and muscle healing protocols in the literature use daily administration for 14-28 days